NEW YORK, Feb. 11, 2014 /PRNewswire/ -- Levi &
Korsinsky is investigating the Board of Directors of Cadence
Pharmaceuticals Inc. ("Cadence" or "the Company") (NasdaqGS: CADX)
for possible breaches of fiduciary duty and other violations of
state law in connection with the sale of the Company to
Mallinckrodt plc.
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)
Click here to learn more about the action
http://zlk.9nl.com/cadence-pharmaceuticals-cadx, or call:
877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Cadence shareholders will
receive $14.00 for each share of
Cadence common stock they own. The investigation concerns whether
the Cadence Board breached their fiduciary duties to stockholders
by failing to adequately shop the Company before agreeing to enter
into this transaction, and whether Mallinckrodt plc is underpaying for Cadence shares.
In particular, at least one analyst set a price target for Cadence
stock at $15.00 per share.
If you own Cadence common stock and wish to obtain additional
information, please contact Joseph E. Levi,
Esq. either via email at jlevi@zlk.com or by telephone at
(212) 363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/cadence-pharmaceuticals-cadx.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
SOURCE Levi & Korsinsky, LLP